Adenocarcinoma and Cholangitis

Summary:

Cholangitis is found among people with Adenocarcinoma, especially for people who are female, 60+ old.

The study analyzes which people have Cholangitis with Adenocarcinoma. It is created by eHealthMe based on reports of 16 people who have Adenocarcinoma from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Adenocarcinoma?

Adenocarcinoma (malignant tumour formed from glandular structures in epithelial tissue) is found to be associated with 411 drugs and 466 conditions by eHealthMe. Check the latest studies of Adenocarcinoma.

What is Cholangitis?

Cholangitis (infection of the bile duct) is found to be associated with 652 drugs and 751 conditions by eHealthMe. Check the latest studies of Cholangitis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

16 people who have Adenocarcinoma and Cholangitis are studied.

Would you have Cholangitis when you have Adenocarcinoma?

Gender of people who have Adenocarcinoma and experienced Cholangitis *:

female: 62.5 %
male: 37.5 %

Age of people who have Adenocarcinoma and experienced Cholangitis *:

Common co-existing conditions for these people *:

Diarrhea: 2 people, 12.50%
Diabetes: 2 people, 12.50%
Adenocarcinoma Pancreas (cancer of pancreas): 2 people, 12.50%
Dyslipidaemia (abnormal amount of lipids): 1 person, 6.25%

Common drugs taken by these people *:

Fluorouracil: 5 people, 31.25%
Levoleucovorin: 2 people, 12.50%
Gemcitabine Hydrochloride: 2 people, 12.50%
Tecentriq: 1 person, 6.25%
Tafinlar: 1 person, 6.25%
Omeprazole: 1 person, 6.25%
Mekinist: 1 person, 6.25%
Loperamide Hydrochloride: 1 person, 6.25%
Lipitor: 1 person, 6.25%
Lansoprazole: 1 person, 6.25%

Common symptoms for these people *:

Fever: 8 people, 50.00%
Back Pain: 7 people, 43.75%
Weakness: 5 people, 31.25%
Hypertransaminasaemia: 5 people, 31.25%
Nausea (feeling of having an urge to vomit): 5 people, 31.25%
Fatigue (feeling of tiredness): 4 people, 25.00%
Diarrhea: 4 people, 25.00%
Sepsis (a severe blood infection that can lead to organ failure and death): 4 people, 25.00%
Dyspnea (difficult or laboured breathing): 3 people, 18.75%
Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration): 3 people, 18.75%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Cholangitis?

- Check whether Cholangitis is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Adenocarcinoma (7,425 reports)
Cholangitis (7,720 reports)

All the drugs that are associated with Cholangitis:

Cholangitis (652 drugs)

All the conditions that are associated with Cholangitis:

Cholangitis (751 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Cholangitis and Adenocarcinoma, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.